<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="793" width="595">
	<fontspec id="0" size="8" family="DLPNDA+AdvTT5235d5a9" color="#231f20"/>
	<fontspec id="1" size="8" family="DLPNDA+AdvTT5235d5a9" color="#2e3191"/>
	<fontspec id="2" size="8" family="DLPNKC+AdvTT5235d5a9+fb" color="#231f20"/>
	<fontspec id="3" size="8" family="DLPNLC+AdvTT5235d5a9+03" color="#231f20"/>
	<fontspec id="4" size="6" family="DLPNLD+AdvTT28000ce1.B" color="#231f20"/>
	<fontspec id="5" size="6" family="DLPNDA+AdvTT5235d5a9" color="#231f20"/>
	<fontspec id="6" size="6" family="DLPNLC+AdvTT5235d5a9+03" color="#231f20"/>
	<fontspec id="7" size="6" family="DLPNKA+AdvTT94c8263f.I" color="#231f20"/>
	<fontspec id="8" size="6" family="DLPOPP+AdvTT454a7a89" color="#231f20"/>
	<fontspec id="9" size="6" family="DLPOHB+AdvTT94c8263f.I+20" color="#231f20"/>
<text top="57" left="43" width="251" height="8" font="0">lowered ATP levels, and KUS121 and esculetin nearly equally sup-</text>
<text top="68" left="43" width="135" height="8" font="0">pressed this reduction in ATP levels <a href="">(</a></text>
<text top="68" left="177" width="19" height="8" font="1"><a href="">Fig. 3</a></text>
<text top="68" left="196" width="97" height="8" font="0">a). Under these conditions,</text>
<text top="78" left="43" width="251" height="8" font="0">KUS121 and esculetin inhibited AMPK activation (evidenced by the</text>
<text top="89" left="43" width="251" height="8" font="0">phosphorylation of AMPK Thr172), as well as CHOP induction, an ER</text>
<text top="99" left="43" width="175" height="8" font="0">stress marker with cell death-inducing activity <a href="">(</a></text>
<text top="99" left="217" width="73" height="8" font="1"><a href="">Zinszner et al., 1998</a></text>
<text top="99" left="290" width="3" height="8" font="0">)</text>
<text top="110" left="43" width="4" height="8" font="0"><a href="">(</a></text>
<text top="110" left="46" width="20" height="8" font="1"><a href="">Fig. 3</a></text>
<text top="110" left="66" width="227" height="8" font="0">b). Consistent with these results, KUS121 and esculetin were</text>
<text top="120" left="43" width="251" height="8" font="0">able to suppress cell death by these mitochondrial respiratory chain in-</text>
<text top="131" left="43" width="33" height="8" font="0">hibitors (</text>
<text top="131" left="76" width="19" height="8" font="1"><a href="">Fig. 3</a></text>
<text top="131" left="94" width="199" height="8" font="0">c, Fig. S2). Interestingly, KUS121 and esculetin appeared</text>
<text top="141" left="43" width="251" height="8" font="0">to more strongly prevent cell death induced by MPP+, rotenone, and</text>
<text top="152" left="43" width="251" height="8" font="0">metformin, which are inhibitors of mitochondrial respiratory chain</text>
<text top="57" left="311" width="251" height="8" font="0">complex I, than antimycin and oligomycin, which are inhibitors of mito-</text>
<text top="68" left="311" width="213" height="8" font="0">chondrial respiratory chain complex III and V, respectively <a href="">(</a></text>
<text top="68" left="523" width="19" height="8" font="1"><a href="">Fig. 3</a></text>
<text top="68" left="542" width="20" height="8" font="0"><a href="">c, </a>Fig.</text>
<text top="78" left="311" width="14" height="8" font="0">S2).</text>
<text top="89" left="322" width="138" height="8" font="0">In order to examine the potential bene</text>
<text top="87" left="460" width="5" height="10" font="2">ﬁ</text>
<text top="89" left="465" width="97" height="8" font="0">ts of KUSs and esculetin for</text>
<text top="99" left="311" width="251" height="8" font="0">Parkinson's disease in more detail, we analyzed the neuroprotective ef-</text>
<text top="108" left="311" width="5" height="10" font="2">ﬁ</text>
<text top="110" left="315" width="246" height="8" font="0">cacies of these compounds with MPP+ exposure. Neuronally differen-</text>
<text top="120" left="311" width="133" height="8" font="0">tiated PC12 cells were treated with 75</text>
<text top="119" left="446" width="4" height="10" font="3">μ</text>
<text top="120" left="450" width="112" height="8" font="0">M MPP+ for 28 h, and then live</text>
<text top="131" left="311" width="156" height="8" font="0">cell (or dead cell) numbers were estimated <a href="">(</a></text>
<text top="131" left="466" width="18" height="8" font="1"><a href="">Fig. 4</a></text>
<text top="131" left="484" width="77" height="8" font="0">a, b, Fig. S3). With this</text>
<text top="141" left="311" width="251" height="8" font="0">treatment, approximately 60% of the cells died. This cell death was not</text>
<text top="152" left="311" width="168" height="8" font="0">inhibited by KUS11 (CAS No. 146293-60-9) (</text>
<text top="152" left="479" width="20" height="8" font="1"><a href="">Fig. 1</a></text>
<text top="152" left="499" width="63" height="8" font="0"><a href="">g)</a>, which has no</text>
<text top="653" left="43" width="17" height="6" font="4">Fig. 3.</text>
<text top="653" left="61" width="501" height="6" font="5">KUS121 and esculetin prevent mitochondrial dysfunction-induced ATP decrease, ER stress, and cell death in neuronally differentiated PC12 cells. (a) Effects of KUS121 and esculetin</text>
<text top="662" left="43" width="519" height="6" font="5">on the prevention of ATP decreases induced by mitochondrial respiratory chain complex inhibitors. Neuronally differentiated PC12 cells were incubated for 24 h in the absence (DMSO) or</text>
<text top="670" left="43" width="51" height="6" font="5">the presence of 50</text>
<text top="669" left="95" width="3" height="8" font="6">μ</text>
<text top="670" left="98" width="46" height="6" font="5">M KUS121 or 50</text>
<text top="669" left="145" width="3" height="8" font="6">μ</text>
<text top="670" left="148" width="314" height="6" font="5">M esculetin, and then further incubated with each of the mitochondrial respiratory chain complex inhibitors (75</text>
<text top="669" left="463" width="3" height="8" font="6">μ</text>
<text top="670" left="466" width="95" height="6" font="5">M MPP+; 10 nM rotenone; 3 mM</text>
<text top="679" left="43" width="100" height="6" font="5">metformin; 100 nM antimycin; 0.01</text>
<text top="678" left="144" width="3" height="8" font="6">μ</text>
<text top="679" left="147" width="415" height="6" font="5">g/ml oligomycin) for 24 h. Then, total ATP amounts and live cell numbers were determined. Mean values of relative ATP levels per cell were calculated</text>
<text top="687" left="43" width="275" height="6" font="5">and are shown, with values for DMSO alone set at 100%. Error bars indicate standard deviations. **</text>
<text top="687" left="318" width="3" height="6" font="7">P</text>
<text top="686" left="323" width="4" height="8" font="8">b</text>
<text top="687" left="328" width="23" height="6" font="5">0.01, ***</text>
<text top="687" left="350" width="3" height="6" font="7">P</text>
<text top="686" left="355" width="4" height="8" font="8">b</text>
<text top="687" left="360" width="120" height="6" font="5">0.001, ANOVA with Tukey's post-hoc test (</text>
<text top="687" left="480" width="4" height="6" font="7">n</text>
<text top="687" left="485" width="77" height="6" font="5">= 4), vs. MPP+, Rotenone,</text>
<text top="696" left="43" width="519" height="6" font="5">Metformin, Antimycin, or Oligomycin alone (-). (b) Effects of KUS121 and esculetin on the prevention of AMPK phosphorylation and ER stress induced by mitochondrial respiratory chain</text>
<text top="704" left="43" width="519" height="6" font="5">complex inhibitors. Neuronally differentiated PC12 cells were cultured with the conditions shown in (a), and were subjected to western blot analyses. Actin served as a loading control. (c)</text>
<text top="713" left="43" width="519" height="6" font="5">Effects of KUS121 and esculetin on the prevention of cell death induced by mitochondrial respiratory chain complex inhibitors. Neuronally differentiated PC12 cells were incubated for 24 h</text>
<text top="721" left="43" width="125" height="6" font="5">in the absence (DMSO) or the presence of 50</text>
<text top="720" left="169" width="3" height="8" font="6">μ</text>
<text top="721" left="172" width="46" height="6" font="5">M KUS121 or 50</text>
<text top="720" left="219" width="3" height="8" font="6">μ</text>
<text top="721" left="222" width="340" height="6" font="5">M esculetin, and then further incubated with each of the mitochondrial respiratory chain complex inhibitors shown in (a)</text>
<text top="730" left="43" width="519" height="6" font="5">for 28 h. Then, live cell numbers were counted by staining with trypan blue. Mean values of relative live cell numbers are shown, with values for DMSO alone set at 100%. Error bars indicate</text>
<text top="739" left="43" width="61" height="6" font="5">standard deviations. *</text>
<text top="739" left="104" width="3" height="6" font="7">P</text>
<text top="738" left="109" width="4" height="8" font="8">b</text>
<text top="739" left="114" width="20" height="6" font="5">0.05, **</text>
<text top="739" left="134" width="3" height="6" font="7">P</text>
<text top="738" left="139" width="4" height="8" font="8">b</text>
<text top="739" left="145" width="138" height="6" font="5">0.01, ANOVA with Games-Howell post-hoc test (</text>
<text top="739" left="283" width="4" height="6" font="7">n</text>
<text top="739" left="288" width="213" height="6" font="5">= 3), vs. MPP+, Rotenone, Metformin, Antimycin, or Oligomycin alone (-).</text>
<text top="38" left="551" width="11" height="6" font="5">231</text>
<text top="38" left="231" width="128" height="6" font="7">M. Nakano et al. / EBioMedicine 22 (2017) 225</text>
<text top="37" left="359" width="4" height="8" font="9">–</text>
<text top="38" left="362" width="10" height="6" font="7">241</text>
</page>
</pdf2xml>
